If you have been reading about DAC group and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | GHRH receptor agonist |
| Sequence length | 29 amino acids | Derived from human GHRH |
| Molecular weight | About 3368 Da without linker | Albumin-binding form is heavier |
| Appearance | White to off-white lyophilized powder | Common form for research reference material |
| Typical storage | -20 °C or below, desiccated | Protect powder from light and moisture |
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
Thebacon is an opioid agonist narcotic analgesic of the middle range and a strong antitussive, primarily used in Europe, although it is no longer in common use. Currently, dihydrocodeine and nicocodeine are used as second-line codeine replacements. The other dihydromorphinone used as an antitussive is hydromorphone (Dilaudid cough syrup); the other narcotic antitussives are either more directly related to codeine or not related at all (open chain methadone relatives and thiambutenes). Thebacon is indicated for moderate to moderately severe pain and dry painful coughing, like hydrocodone. It has a duration of action in the range of 5 to 9 hours and doses typically start at 5 mg q6h. For both pain and coughing, thebacon can be made more effective along with NSAIDs, muscle relaxants, and/or antihistamines like tripelennamine, hydroxyzine, promethazine, phenyltoloxamine and chlorpheniramine.
In 1933, Fermi published his landmark theory for beta decay, where he applied the principles of quantum mechanics to matter particles, supposing that they can be created and annihilated, just as the light quanta in atomic transitions. Thus, according to Fermi, neutrinos are created in the beta-decay process, rather than contained in the nucleus; the same happens to electrons. The neutrino interaction with matter was so weak that detecting it proved a severe experimental challenge. Further indirect evidence of the existence of the neutrino was obtained by observing the recoil of nuclei that emitted such a particle after absorbing an electron. Neutrinos were finally detected directly in 1956 by the American physicists Clyde Cowan and Frederick Reines in the Cowan–Reines neutrino experiment. The properties of neutrinos were (with a few minor modifications) as predicted by Pauli and Fermi.
Dale Stevens of The Cincinnati Post called it "a respectable film, beautifully photographed, especially in the many action scenes", which "offers two lessons: (1) a decent movie can be made about bikers (2) Brian Bosworth, a controversial football player, can become an actor in the Schwarzenegger mold." Similarly, Joe Leydon of the The Houston Post commended Bosworth and deemed that "Stone Cold is a rude and undeniably exciting exploitation flick, a dum-dum bullet of a movie that races from one explosion of high-testosterone ultraviolence to the next, often leaving the audience slack-jawed through the sheer audacity of its excess."
Sources: en.wikipedia.org
=== Libertarianism and capitalism === In a 2001 interview with Reason, Hitchens said he had been interested in libertarian ideas when he was younger, but set aside those interests in the 1960s. He stated that capitalism had become the more revolutionary economic system, and he welcomed globalisation as "innovative and internationalist", but added, "I don't think that the contradictions, as we used to say, of the system, are by any means all resolved." He also stated that he had a renewed interest in the freedom of the individual from the state, but that he still considered libertarianism "ahistorical" both on the world stage and in the work of creating a stable and functional society, adding that libertarians are "more worried about the over-mighty state than the unaccountable corporation" whereas "the present state of affairs ... combines the worst of bureaucracy with the worst of the insurance companies." He also said that libertarians did not have a clear foreign policy stance. In a 2001 C-SPAN appearance, he told a caller:
=== Medicinal === For the Nuba tribe of Sudan, scars can serve a medicinal purpose; scars above the eyes are believed to improve eyesight, and scars on the temples are believed to help relieve headaches. In some cultures, scarification is used in traditional medicine to treat some illness by inserting medicine (usually herbs or powdered root) under the skin to heal a variety of infections and illnesses such as Malaria.
=== 2018–present === On January 9, 2018, construction workers broke ground on a new 5,100 square foot (470 m2) wound healing center at the hospital, it would be double the size of the old facility. The wound healing center was completed at the end of 2018 and included six treatment rooms, three hyperbaric chambers, waiting area and a lobby. On May 22, 2019, AdventHealth signed a definitive agreement to purchase Lake Wales Medical Center from Community Health Systems. On September 1, AdventHealth took over the management of Lake Wales Medical Center, it had purchased the hospital for $10,146,000 and renamed it AdventHealth Lake Wales. On January 1, 2021, all hospitals were required to have their chargemaster on its website by the Centers for Medicare & Medicaid Services. In early February, 2023, almost all of the AdventHealth hospitals had their chargemaster on their website, including AdventHealth Lake Wales.
Junior doctors in England vote to strike in their ongoing dispute for a 26% pay rise, and will stage a 72-hour walkout. The BMA maintains junior doctors' pay has been cut by 26% since 2008 after inflation is considered. 21 February The UK Government announces that it had a budget surplus in January, with £5bn more in revenue than predicted. A planned 48-hour strike by nurses in England is called off to allow the Royal College of Nursing and Department of Health and Social Care to enter into renewed negotiations. The broadcasting regulator Ofcom writes to both ITV News and Sky News to ask them for an explanation of their actions following complaints made by the family of Nicola Bulley. Her family had been contacted by both outlets despite asking for privacy. Asda and Morrisons announce they are limiting the sale of some fruit and vegetable products, such as tomatoes, peppers and cucumbers, because of a shortage caused by severe weather in Spain and North Africa which has affected harvests. The UK Government recommends a 3.5% pay rise for public sector workers in England, below the rate of inflation. 22 February Shamima Begum loses her legal challenge to overturn the decision to remove her UK citizenship. Tesco and Aldi Süd follow Asda and Morrisons by introducing limits on the purchase of some fruit and vegetables. Lancashire Police and Crime Commissioner Andrew Snowden commissions the College of Policing to review the force's investigation into the disappearance of Nicola Bulley, including the release of information about her private life.
Sources: en.wikipedia.org
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.
The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.
It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.